home / stock / sonn / sonn short
Short Information | Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 528,317 |
Total Actual Volume | 4,655,315 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 26,416 |
Average Short Percentage | 17.51% |
Is there a SONN Short Squeeze or Breakout about to happen?
See the SONN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-28-2024 | $1.97 | $1.86 | $1.97 | $1.8 | 70,350 | 1,672 | 2.38% |
03-27-2024 | $1.95 | $2.03 | $2.03 | $1.9 | 42,502 | 4,134 | 9.73% |
03-26-2024 | $2.08 | $2.035 | $2.17 | $1.9662 | 45,580 | 7,032 | 15.43% |
03-25-2024 | $2.15 | $2.0834 | $2.23 | $2.0501 | 17,451 | 2,053 | 11.76% |
03-22-2024 | $2.15 | $2.14 | $2.2187 | $2.06 | 51,327 | 16,921 | 32.97% |
03-21-2024 | $2.06 | $2.1401 | $2.1401 | $2.0368 | 56,832 | 6,904 | 12.15% |
03-20-2024 | $2.2 | $2.07 | $2.2664 | $1.95 | 81,874 | 13,701 | 16.73% |
03-19-2024 | $2.27 | $2.18 | $2.3273 | $2.1201 | 67,042 | 8,569 | 12.78% |
03-18-2024 | $2.02 | $2.26 | $2.3399 | $2.02 | 276,839 | 83,815 | 30.28% |
03-15-2024 | $1.68 | $2.02 | $2.1199 | $1.67 | 141,743 | 41,479 | 29.26% |
03-14-2024 | $1.83 | $1.67 | $1.835 | $1.65 | 75,706 | 14,202 | 18.76% |
03-13-2024 | $1.79 | $1.79 | $1.835 | $1.7652 | 62,308 | 10,059 | 16.14% |
03-12-2024 | $1.94 | $1.8 | $2 | $1.79 | 182,872 | 23,475 | 12.84% |
03-11-2024 | $2.05 | $2.07 | $2.21 | $1.86 | 3,158,749 | 238,695 | 7.56% |
03-08-2024 | $1.94 | $1.85 | $2 | $1.85 | 59,074 | 7,402 | 12.53% |
03-07-2024 | $1.9 | $1.91 | $1.93 | $1.85 | 24,741 | 9,219 | 37.26% |
03-06-2024 | $1.92 | $1.92 | $1.96 | $1.841 | 49,512 | 4,072 | 8.22% |
03-05-2024 | $1.88 | $1.9 | $1.94 | $1.82 | 29,663 | 9,194 | 30.99% |
03-04-2024 | $1.89 | $1.89 | $1.89 | $1.75 | 60,046 | 10,188 | 16.97% |
03-01-2024 | $1.98 | $1.81 | $1.98 | $1.73 | 101,104 | 15,531 | 15.36% |
News, Short Squeeze, Breakout and More Instantly...
Sonnet BioTherapeutics Holdings Inc. Company Name:
SONN Stock Symbol:
NASDAQ Market:
PRINCETON, NJ / ACCESSWIRE / March 19, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that preclinical data and clinical trial design from the study of SON-080 (rec...
Safety in the Phase 1b part of Sonnet's double-blind, randomized, controlled trial of SON‑080 was reviewed by the study's Data Safety Monitoring Board (DSMB) The adverse event profile and tolerability of SON-080 was consistent with data from previous IL-6 candidates, meeting the Phase...
PRINCETON, NJ / ACCESSWIRE / February 29, 2024 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today the publication of clinical data on SON-1010 in Frontiers in Immunology . SON-1010, Sonnet's lea...